Phase II Trial of Vorinostat plus Tacrolimus and Mycophenolate to Prevent Graft versus Host Disease Following Reduced Intensity Conditioning Related Donor Allogeneic Transplant
Show full item record

This item appears in the following Collection(s)


Search Deep Blue

Advanced Search

Browse by

My Account

Information

Coming Soon


MLibrary logo